APA

Hansen K., Hovmark A., Lebech A. M., Lebech K., Olsson I., Halkier-Sørensen L., Olsson E. & Asbrink E. (19921123). Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. : Acta dermato-venereologica.

Chicago

Hansen K, Hovmark A, Lebech A M, Lebech K, Olsson I, Halkier-Sørensen L, Olsson E and Asbrink E. 19921123. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. : Acta dermato-venereologica.

Harvard

Hansen K., Hovmark A., Lebech A. M., Lebech K., Olsson I., Halkier-Sørensen L., Olsson E. and Asbrink E. (19921123). Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. : Acta dermato-venereologica.

MLA

Hansen K, Hovmark A, Lebech A M, Lebech K, Olsson I, Halkier-Sørensen L, Olsson E and Asbrink E. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. : Acta dermato-venereologica. 19921123.